Contact this Provider:
- Radiation Oncology
- acoustic neuroma
- adenocarcinoma of the head and neck
- anal cancer
- arteriovenous malformation (avm)
- astrocytoma tumors Show All
- 3d conformal radiation therapy
- balloon breast brachytherapy
- brachytherapy
- chemoradiation
- combined modality therapy Show All
Brian Collins, MD, is medical director of the Department of Radiation Medicine at MedStar Georgetown University Hospital and an assistant professor at Georgetown University School of Medicine. Dr. Collins joined the staff in 2001 after completing his residency at MedStar Georgetown. Previously, he received his medical degree from SUNY-Stony Brook, and fulfilled his internship at St. Vincent's Hospital and Medical Center in New York City.
Board certified in Radiation Oncology, Dr. Collins has a particular interest in treating central nervous system cancers, lung cancers and breast cancers. He is a recognized specialist in CyberKnife radiotherapy technology.
A frequent contributor to scientific journals, books and publications, he also sits on several editorial review boards.
Dr. Collins is a Fellow in the American College of Chest Physicians (ACCP) and a member of numerous related organizations.
Conditions Treated:
- Central nervous system tumors/arteriovenous malformations (AVM)
- Thoracic cancers
- Breast cancer
Procedures Performed:
- Proton therapy
- CyberKnife stereotactic radiosurgery (SRS)
- CyberKnife stereotactic body radiation therapy (SBRT)
- Intensity-modulated radiation therapy/image-guided radiation therapy (IMRT/IGRT/Rapid Arc)
- Brachytherapy
- ZAP-X® Gyroscopic Radiosurgery™ (SRS)
- Residency Program: MedStar Georgetown University Hospital (2000)
- Internship Program: St. Vincents Hospital and Medical Center (1996)
- Medical School: State University of New York at Stony Brook (1995)
- Board Certification: American Board of Radiology, Radiation Oncology
Lischalk JW, Woo SM, Kataria S, Aghdam N, Paydar I, Repka MC, Anderson ED, Collins BT.Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol. 2016;5(4):379-387. doi: 10.1007/s13566-016-0273-4.PMID:28018523
Obayomi-Davies O, Kole TP, Oppong B, Rudra S, Makariou EV, Campbell LD, Anjum HM, Collins SP, Unger K, Willey S, Tousimis E, Collins BT. Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform. Front Oncol. 2016 May 23;6:129. doi: 10.3389/fonc.2016.00129.PMID:27242967
Kress MA, Oermann E, Ewend MG, Hoffman RB, Chaudhry H, Collins B. Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure. Radiat Oncol. 2013 Mar 19;8:64. doi: 10.1186/1748-717X-8-64.PMID:23510318
Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT. Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach. Front Oncol. 2012 Apr 26;2:39. doi: 10.3389/fonc.2012.00039. PMID:22645718
Oermann E, Collins BT, Erickson KT, Yu X, Lei S, Suy S, Hanscom HN, Kim J, Park HU, Eldabh A, Kalhorn C, McGrail K, Subramaniam D, Jean WC, Collins SP. CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. J Hematol Oncol. 2010 Jun 9;3:22. doi: 10.1186/1756-8722-3-22.PMID:20534128
